3-Pyridinylboronic acid → 4-(9-methyl-8-((4-(methylsulfonyl)piperazin-1-yl)methyl)-2-(pyridin-3-yl)-9H-purin-6-yl)morpholine
반응식
[Cl:1][c:2]1[n:3][c:4]([N:23]2[CH2:24][CH2:25][O:26][CH2:27][CH2:28]2)[c:5]2[n:6][c:7]([CH2:12][N:13]3[CH2:14][CH2:15][N:16]([S:19](=[O:20])(=[O:21])[CH3:22])[CH2:17][CH2:18]3)[n:8]([CH3:11])[c:9]2[n:10]1.[n:29]1[cH:30][c:31]([B:35]([OH:36])[OH:37])[cH:32][cH:33][cH:34]1>>[c:2]1(-[c:31]2[cH:30][n:29][cH:34][cH:33][cH:32]2)[n:3][c:4]([N:23]2[CH2:24][CH2:25][O:26][CH2:27][CH2:28]2)[c:5]2[n:6][c:7]([CH2:12][N:13]3[CH2:14][CH2:15][N:16]([S:19](=[O:20])(=[O:21])[CH3:22])[CH2:17][CH2:18]3)[n:8]([CH3:11])[c:9]2[n:10]1참가 물질
3
출처 및 근거
- ORD 기록
- ord-780e92d00b3d4e83b2c7dd5d1c8904bf
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (1/10)
반응 노트
불러오는 중…